Results 111 to 120 of about 82,604 (202)

BRAF Inhibitor PLX8394 [PDF]

, 2020
openaire   +1 more source

Resistance to BRAF Inhibitors: EZH2 and Its Downstream Targets as Potential Therapeutic Options in Melanoma. [PDF]

Int J Mol Sci, 2023
Uebel A, Kewitz-Hempel S, Willscher E, Gebhardt K, Sunderkötter C, Gerloff D.   +5 more
europepmc   +1 more source

M-CSF as a therapeutic target in BRAF^V600E melanoma resistant to BRAF inhibitors. [PDF]

Br J Cancer, 2022
Barceló C, Sisó P, de la Rosa I, Megino-Luque C, Navaridas R, Maiques O, Urdanibia I, Eritja N, Soria X, Potrony M, Calbet-Llopart N, Puig S, Matías-Guiu X, Martí RM, Macià A.   +14 more
europepmc   +1 more source

Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer

Cancer Management and Research, 2018
Jing-hua Pan,1 Hong Zhou,2 Sheng-bin Zhu,1 Jin-lian Huang,1 Xiao-xu Zhao,1 Hui Ding,1 Yun-long Pan1 1Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China; 2Department of Gynecology, The First ...
Pan JH, Zhou H, Zhu SB, Huang JL, Zhao XX, Ding H, Pan YL   +6 more
doaj  

Development and validation of an LC-MS/MS method to measure the BRAF inhibitors dabrafenib and encorafenib quantitatively and four major metabolites semi-quantitatively in human plasma. [PDF]

J Pharm Biomed Anal, 2023
Myszkiewicz MF, Puzanov I, Goey AKL.
europepmc   +1 more source

BRAF Inhibitors in Melanoma Management: When Friends Become Foes. [PDF]

J Invest Dermatol, 2022
Chhabra G, Ahmad N.
europepmc   +1 more source

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents [PDF]

, 2017
Abraham, Christopher, Acharya, Sahaja, Chicoine, Michael, Dowling, Joshua, Dunn, Gavin, Huang, Jiayi, Keller, Jesse, Leuthardt, Eric, Mahmood, Mustafaa, Mullen, Daniel, Perkins, Stephanie M, Rich, Keith, Robinson, Clifford G, Tsien, Christina I, Yang, Deshan   +14 more
core   +2 more sources

Transformer-Based Generative Model Accelerating the Development of Novel BRAF Inhibitors. [PDF]

ACS Omega, 2021
Yang L, Yang G, Bing Z, Tian Y, Niu Y, Huang L, Yang L.   +6 more
europepmc   +1 more source

Androgen receptor-dependent DRAM1 activation drives autophagic resistance to BRAF inhibitors in BRAFV600-mutant melanoma. [PDF]

Cell Death Dis
Zhi D, Wu B, Yang J, Wang D, Qiao J, Guo F.   +5 more
europepmc   +1 more source

Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy. [PDF]

Sci Adv, 2022
Ng TSC, Hu H, Kronister S, Lee C, Li R, Gerosa L, Stopka SA, Burgenske DM, Khurana I, Regan MS, Vallabhaneni S, Putta N, Scott E, Matvey D, Giobbie-Hurder A, Kohler RH, Sarkaria JN, Parangi S, Sorger PK, Agar NYR, Jacene HA, Sullivan RJ, Buchbinder E, Mikula H, Weissleder R, Miller MA.   +25 more
europepmc   +1 more source